4-(4-methylpiperazinomethyl)-4'-trifluoromethylbenzophenone, 97.0%, 1g

6-Fluoro-7-morpholin-4-yl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 5g

O-(Prop-2-yn-1-yl)hydroxylamine hydrochloride, 95.0%, 1g

Methyl 2-(Bromomethyl)acrylate>97.0%(GC)1g

L-arginine monohydrochloride, min. 98.5%, Ph.Eur., USP, 250 g, plastic packaging.

(2R,4R)-1-(TERT-BUTOXYCARBONYL)-4-CYANOPYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 500mg

1-(2,2,2-Trifluoroethyl)piperidine-2,4-dione, 98%, 250mg

20 ml Cylindrical jar PP white RD 25 round

ETHYL 2-(6-HYDROXY-2,3-DIHYDROBENZO[B]THIOPHEN-3-YL)ACETATE, 95.0%, 2g

2,5-Dimethyltetrahydrofuran (stabilized with BHT), 95.0%, 25ml

Scintillation vials Volume 6.5ml, HDPE, 2, 1000 Piece(s)

4-METHYL-6-NITRO-1H-INDAZOLE, 98%, 25g

Methyl N-[1H-1,2,3-benzotriazol-1-yl(phenyl)methyl]carbamate, 90.0%, 100mg